Hagens Berman Reminds Corcept Therapeutics (NASDAQ: CORT) Investors of May 13, 2019 Lead Plaintiff Deadline
San Francisco - Hagens Berman Sobol Shapiro LLP reminds investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) of the May 13, 2019 Lead Plaintiff deadline in the pending securities class action. If you purchased or otherwise acquired Corcept Therapeutics securities between August 2, 2017 and February 5, 2019 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information or to inquire about serving as Lead Plaintiff click
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing
According to the complaint, during the class period Defendants misled investors by concealing (a) improper payments to doctors to promote its drug Korlym, (b) its aggressive promotion of Korlym for off-label uses, and (c) the possibility that the Company’s sole specialty pharmacy was a related party.
In response to reports highlighting this- and other- potential misconduct, the price of Corcept shares has significantly fallen.
“We’re focused on investors’ losses and whether Defendants used a captured pharmacy to improperly boost sales or hide losses,” said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding Corcept should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email CORT@hbsslaw.com.
# # #
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with 78 attorneys in 9 offices across the country. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Reed Kathrein, 510-725-3000
Hagens Berman purchases advertisements on search engines, social media sites and other websites. Transmission of the information contained or available through this website is not intended to create, and receipt does not constitute, an attorney-client relationship. If you seek legal advice or representation by Hagens Berman, you must first enter a formal agreement. All information contained in any transmission is confidential and Hagens Berman agrees to protect information against unauthorized use, publication or disclosure. This site is regulated by the Washington Rules of Professional Conduct.